Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Dave Truch, Technology Director, Digital Innovation Organization, BP
Jan Schnorr, CEO, C2Sense
Natalya Baily, CEO & Cofounder, Accion
Yet-Ming Chiang, Cofounder & Chief Scientist, 24M Rick Feldt, President, 24M
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
Trond Undheim, Program Director, MIT Startup Exchange
Panel moderator: Marcus Dahllof, Program Director, MIT Startup Exchange Panelists: Caleb Harper, Director, OpenAg, MIT Media Lab Dilip Sundaram, President, Corporate, Mahindra Group - Americas Jan Schnorr, CEO, C2Sense Alan Kriz, Strategic Alliance Manager, Crop Science, Bayer Tejal Mody, Managing Director, Rabobank
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.
Alan Kriz - Open Innovation and Investment